244 related articles for article (PubMed ID: 31752169)
1. Heat Shock Proteins in Glioblastoma Biology: Where Do We Stand?
Iglesia RP; Fernandes CFL; Coelho BP; Prado MB; Melo Escobar MI; Almeida GHDR; Lopes MH
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31752169
[TBL] [Abstract][Full Text] [Related]
2. Exploiting Iron Metabolism as a Therapeutic Vulnerability in Glioblastoma.
Nabavizadeh A; Bagley SJ
Clin Cancer Res; 2024 Jan; 30(2):255-256. PubMed ID: 37982809
[TBL] [Abstract][Full Text] [Related]
3. Hsp70 and Calcitonin Receptor Protein in Extracellular Vesicles from Glioblastoma Multiforme: Biomarkers with Putative Roles in Carcinogenesis and Potential for Differentiating Tumor Types.
Alberti G; Sánchez-López CM; Marcilla A; Barone R; Caruso Bavisotto C; Graziano F; Conway de Macario E; Macario AJL; Bucchieri F; Cappello F; Campanella C; Rappa F
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542389
[TBL] [Abstract][Full Text] [Related]
4. Flavonoids Regulate Redox-Responsive Transcription Factors in Glioblastoma and Microglia.
Joma N; Zhang I; Righetto GL; McKay L; Gran ER; Kakkar A; Maysinger D
Cells; 2023 Dec; 12(24):. PubMed ID: 38132142
[TBL] [Abstract][Full Text] [Related]
5. Quercetin and Its Nano-Formulations for Brain Tumor Therapy-Current Developments and Future Perspectives for Paediatric Studies.
Shala AL; Arduino I; Salihu MB; Denora N
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986827
[TBL] [Abstract][Full Text] [Related]
6. IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axis.
Lin W; Niu R; Park SM; Zou Y; Kim SS; Xia X; Xing S; Yang Q; Sun X; Yuan Z; Zhou S; Zhang D; Kwon HJ; Park S; Il Kim C; Koo H; Liu Y; Wu H; Zheng M; Yoo H; Shi B; Park JB; Yin J
Nat Commun; 2023 Mar; 14(1):1578. PubMed ID: 36949068
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics and Metabolism Reprogramming Interplay into Glioblastoma: Novel Insights on Immunosuppressive Mechanisms.
Torrisi F; D'Aprile S; Denaro S; Pavone AM; Alberghina C; Zappalà A; Giuffrida R; Salvatorelli L; Broggi G; Magro GG; Calabrese V; Vicario N; Parenti R
Antioxidants (Basel); 2023 Jan; 12(2):. PubMed ID: 36829778
[TBL] [Abstract][Full Text] [Related]
8. Targeting Heat Shock Proteins in Malignant Brain Tumors: From Basic Research to Clinical Trials.
Babi A; Menlibayeva K; Bex T; Doskaliev A; Akshulakov S; Shevtsov M
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358853
[TBL] [Abstract][Full Text] [Related]
9. Codon Usage and mRNA Stability are Translational Determinants of Cellular Response to Canonical Ferroptosis Inducers.
Rashad S; Byrne SR; Saigusa D; Xiang J; Zhou Y; Zhang L; Begley TJ; Tominaga T; Niizuma K
Neuroscience; 2022 Oct; 501():103-130. PubMed ID: 35987429
[TBL] [Abstract][Full Text] [Related]
10. Low MxA Expression Predicts Better Immunotherapeutic Outcomes in Glioblastoma Patients Receiving Heat Shock Protein Peptide Complex 96 Vaccination.
Wang Y; Li C; Chi X; Huang X; Gao H; Ji N; Zhang Y
Front Oncol; 2022; 12():865779. PubMed ID: 35903678
[TBL] [Abstract][Full Text] [Related]
11. Unconventional Protein Secretion in Brain Tumors Biology: Enlightening the Mechanisms for Tumor Survival and Progression.
Iglesia RP; Prado MB; Alves RN; Escobar MIM; Fernandes CFL; Fortes ACDS; Souza MCDS; Boccacino JM; Cangiano G; Soares SR; de Araújo JPA; Tiek DM; Goenka A; Song X; Keady JR; Hu B; Cheng SY; Lopes MH
Front Cell Dev Biol; 2022; 10():907423. PubMed ID: 35784465
[TBL] [Abstract][Full Text] [Related]
12. Cell-based immunotherapy of glioblastoma multiforme.
Bryukhovetskiy I
Oncol Lett; 2022 Apr; 23(4):133. PubMed ID: 35251352
[TBL] [Abstract][Full Text] [Related]
13. Investigating Glioblastoma Multiforme Sub-Proteomes: A Computational Study of CUSA Fluid Proteomic Data.
Moresi F; Rossetti DV; Vincenzoni F; Simboli GA; La Rocca G; Olivi A; Urbani A; Sabatino G; Desiderio C
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216175
[TBL] [Abstract][Full Text] [Related]
14. Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90.
Saha T; van Vliet AA; Cui C; Macias JJ; Kulkarni A; Pham LN; Lawler S; Spanholtz J; Georgoudaki AM; Duru AD; Goldman A
Front Mol Biosci; 2021; 8():754443. PubMed ID: 34926577
[TBL] [Abstract][Full Text] [Related]
15. Injectable biomaterials for treatment of glioblastoma.
Anderson AR; Segura T
Adv Mater Interfaces; 2020 Oct; 7(20):. PubMed ID: 34660174
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Potential of Selenium in Glioblastoma.
Yakubov E; Eibl T; Hammer A; Holtmannspötter M; Savaskan N; Steiner HH
Front Neurosci; 2021; 15():666679. PubMed ID: 34121995
[TBL] [Abstract][Full Text] [Related]
17. Heat Shock Protein Inhibitor 17-Allyamino-17-Demethoxygeldanamycin, a Potent Inductor of Apoptosis in Human Glioma Tumor Cell Lines, Is a Weak Substrate for ABCB1 and ABCG2 Transporters.
Pastvova N; Dolezel P; Mlejnek P
Pharmaceuticals (Basel); 2021 Jan; 14(2):. PubMed ID: 33573093
[TBL] [Abstract][Full Text] [Related]
18. Multifaceted WNT Signaling at the Crossroads Between Epithelial-Mesenchymal Transition and Autophagy in Glioblastoma.
Coelho BP; Fernandes CFL; Boccacino JM; Souza MCDS; Melo-Escobar MI; Alves RN; Prado MB; Iglesia RP; Cangiano G; Mazzaro GR; Lopes MH
Front Oncol; 2020; 10():597743. PubMed ID: 33312955
[TBL] [Abstract][Full Text] [Related]
19. Molecular Characterization of Temozolomide-Treated and Non Temozolomide-Treated Glioblastoma Cells Released Extracellular Vesicles and Their Role in the Macrophage Response.
Panzarini E; Tacconi S; Carata E; Mariano S; Tata AM; Dini L
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171763
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy with heat shock protein 96 to treat gliomas.
Li C; Du Y; Zhang Y; Ji N
Chin Neurosurg J; 2020; 6():31. PubMed ID: 32922959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
